Published in J Exp Med on January 05, 1998
Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol (2009) 2.19
CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest (2009) 2.15
Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development. J Clin Invest (2001) 1.85
Gene conversion causing human inherited disease: evidence for involvement of non-B-DNA-forming sequences and recombination-promoting motifs in DNA breakage and repair. Hum Mutat (2009) 1.64
Early B cell defects. Clin Exp Immunol (2000) 1.43
Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J Exp Med (2014) 1.41
Antigen receptor engagement turns off the V(D)J recombination machinery in human tonsil B cells. J Exp Med (1998) 1.36
Mutations in Igalpha (CD79a) result in a complete block in B-cell development. J Clin Invest (1999) 1.32
Clinical consequences of defects in B-cell development. J Allergy Clin Immunol (2010) 1.19
The role of copy number variation in susceptibility to amyotrophic lateral sclerosis: genome-wide association study and comparison with published loci. PLoS One (2009) 1.19
Mutations in btk in patients with presumed X-linked agammaglobulinemia. Am J Hum Genet (1998) 1.19
The genetic theory of infectious diseases: a brief history and selected illustrations. Annu Rev Genomics Hum Genet (2013) 1.17
Genomic regions showing copy number variations associate with resistance or susceptibility to gastrointestinal nematodes in Angus cattle. Funct Integr Genomics (2011) 1.13
A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans. J Clin Invest (2003) 1.09
A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD). Blood (2013) 1.03
Analysis of mice with single and multiple copies of transgenes reveals a novel arrangement for the lambda5-VpreB1 locus control region. Mol Cell Biol (1999) 1.01
Clinical and molecular analysis of patients with defects in micro heavy chain gene. J Clin Invest (2002) 1.00
The molecular pathology of primary immunodeficiencies. J Mol Diagn (2004) 0.98
Mutations of the Igbeta gene cause agammaglobulinemia in man. J Exp Med (2007) 0.95
Novel mechanisms control the folding and assembly of lambda5/14.1 and VpreB to produce an intact surrogate light chain. Proc Natl Acad Sci U S A (1999) 0.92
Fit for life in the immune system? Surrogate L chain tests H chains that test L chains. Proc Natl Acad Sci U S A (1999) 0.89
Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinaemic males registered as common variable immunodeficiency (CVID) in the Japanese Immunodeficiency Registry. Clin Exp Immunol (2000) 0.88
Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clin Exp Immunol (2004) 0.86
Genes required for B cell development. J Clin Invest (2003) 0.84
Agammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19. Blood (2011) 0.83
VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia. Leukemia (2013) 0.82
Immunoglobulin beta signaling regulates locus accessibility for ordered immunoglobulin gene rearrangements. J Exp Med (2000) 0.80
Pre-B cell receptor signaling in acute lymphoblastic leukemia. Cell Cycle (2009) 0.80
Immunogenetics: changing the face of immunodeficiency. J Clin Pathol (2000) 0.79
Autoantibodies: Focus on anti-DNA antibodies. Self Nonself (2011) 0.79
The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review. Allergy Asthma Clin Immunol (2010) 0.79
The Sel1L-Hrd1 Endoplasmic Reticulum-Associated Degradation Complex Manages a Key Checkpoint in B Cell Development. Cell Rep (2016) 0.76
The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas. Haematologica (2010) 0.76
Copy number variation of genes involved in the hepatitis C virus-human interactome. Sci Rep (2016) 0.75
Igalpha: B all that you can B. J Clin Invest (1999) 0.75
Heterogeneity of Human Neutrophil CD177 Expression Results from CD177P1 Pseudogene Conversion. PLoS Genet (2016) 0.75
Complete arrest from pro- to pre-B cells in a case of B cell-negative severe combined immunodeficiency (SCID) without recombinase activating gene (RAG) mutations. Clin Exp Immunol (2001) 0.75
Atypical X-linked agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin M deficiency patient. BMC Pediatr (2013) 0.75
Autosomal recessive agammaglobulinemia: the third case of Igβ deficiency due to a novel non-sense mutation. J Clin Immunol (2014) 0.75
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature (1991) 13.19
Clonal selection and learning in the antibody system. Nature (1996) 9.58
Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med (1995) 7.52
The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature (1993) 7.39
Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell (1993) 5.37
Nonsense mutations in the dihydrofolate reductase gene affect RNA processing. Mol Cell Biol (1989) 5.19
A hyperconversion mechanism generates the chicken light chain preimmune repertoire. Cell (1987) 4.23
Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int Immunol (1993) 3.67
Three-dimensional structure of immunoglobulins. Annu Rev Biochem (1979) 3.66
A critical role of lambda 5 protein in B cell development. Cell (1992) 3.09
Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev (1994) 3.00
Variable amplification of immunoglobulin lambda light-chain genes in human populations. Nature (1983) 2.75
Lambda 5, a new light-chain-related locus selectively expressed in pre-B lymphocytes. Nature (1987) 2.43
A second gene, VpreB in the lambda 5 locus of the mouse, which appears to be selectively expressed in pre-B lymphocytes. EMBO J (1987) 2.39
Beta-globin nonsense mutation: deficient accumulation of mRNA occurs despite normal cytoplasmic stability. Proc Natl Acad Sci U S A (1992) 2.13
Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med (1996) 2.10
Formation of disulphide-linked mu 2 omega 2 tetramers in pre-B cells by the 18K omega-immunoglobulin light chain. Nature (1987) 2.09
B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states. J Immunol (1978) 1.88
The surrogate light chain in B-cell development. Immunol Today (1993) 1.64
Mu heavy chains can associate with a pseudo-light chain complex (psi L) in human pre-B cell lines. Int Immunol (1989) 1.59
Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation. Genes Dev (1994) 1.58
B cells in patients with X-linked agammaglobulinemia. J Immunol (1985) 1.48
Molecular chaperones involved in protein degradation in the endoplasmic reticulum: quantitative interaction of the heat shock cognate protein BiP with partially folded immunoglobulin light chains that are degraded in the endoplasmic reticulum. Proc Natl Acad Sci U S A (1995) 1.46
Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis. Hum Mol Genet (1994) 1.44
Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J Immunol (1990) 1.35
Short gene conversions in the human fetal globin gene region: a by-product of chromosome pairing during meiosis? Genetics (1986) 1.31
Organization of the human immunoglobulin lambda light-chain locus on chromosome 22q11.2. Hum Mol Genet (1995) 1.24
Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage. EMBO J (1996) 1.23
Light-chain gene expression before heavy-chain gene rearrangement in pre-B cells transformed by Epstein-Barr virus. Proc Natl Acad Sci U S A (1989) 1.22
Creation of immunoglobulin diversity by intrachromosomal gene conversion. Trends Genet (1992) 1.18
Identification of three new Ig lambda-like genes in man. J Exp Med (1986) 1.12
Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Hum Mol Genet (1994) 1.11
B cell development in mice with a defective lambda 5 gene. Eur J Immunol (1993) 1.06
Hypoimmunoglobulinemia with normal T cell function in female siblings. Clin Immunol Immunopathol (1977) 1.03
Interleukin 7 independent development of human B cells. Proc Natl Acad Sci U S A (1996) 1.01
Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia. Hum Mol Genet (1994) 1.01
Fate of surrogate light chains in B lineage cells. J Exp Med (1996) 0.99
Evaluation of lymphocyte differentiation in primary and secondary immunodeficiency diseases. J Immunol (1985) 0.97
Females with a disorder phenotypically identical to X-linked agammaglobulinemia. J Clin Immunol (1992) 0.92
Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence. Proc Natl Acad Sci U S A (1994) 0.92
Pre-B lymphocyte-specific transcriptional control of the mouse VpreB gene. Eur J Immunol (1992) 0.91
Organization and expression of the lambda-like genes that contribute to the mu-psi light chain complex in human pre-B cells. Int Immunol (1991) 0.90
Surrogate or conventional light chains are required for membrane immunoglobulin mu to activate the precursor B cell transition. J Exp Med (1996) 0.89
B cell development and differentiation. Curr Opin Immunol (1997) 0.86
Predominance of sterile immunoglobulin transcripts in a female phenotypically resembling Bruton's agammaglobulinemia. Eur J Immunol (1995) 0.85
Physical location of the human immunoglobulin lambda-like genes, 14.1, 16.1, and 16.2. Immunogenetics (1993) 0.84
Cell surface expression of surrogate light chain (psi L) in the absence of mu on human pro-B cell lines and normal pro-B cells. Eur J Immunol (1996) 0.81
Composite exon structure of an unusual Ig lambda-like gene located at human 22q11 position. Mamm Genome (1996) 0.79
Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med (1977) 9.57
CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science (1993) 5.04
The T cell dependence of B cell differentiation induced by pokeweed mitogen. J Immunol (1976) 4.40
The functions of the thymus system and the bursa system in the chicken. J Exp Med (1966) 4.07
Immunofluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans. Eur J Immunol (1977) 4.00
The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva. J Exp Med (1966) 3.97
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med (1999) 3.78
Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors. J Neurophysiol (1998) 3.67
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia (2004) 3.59
Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med (1968) 3.54
Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix, and Peyer's patches. An electron microscopic study. Am J Anat (1973) 3.38
Suppression of immunoglobulin class synthesis in mice. I. Effects of treatment with antibody to -chain. J Exp Med (1972) 3.32
Early production of intracellular IgM by B-lymphocyte precursors in mouse. Nature (1976) 3.29
A map of local adaptation in Arabidopsis thaliana. Science (2011) 3.27
The spectrum of the DiGeorge syndrome. J Pediatr (1979) 3.24
Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet (1998) 3.07
Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. J Exp Med (1980) 3.03
Suppression of immunoglobulin G synthesis as a result of antibody-mediated suppression of immunoglobulin M synthesis in chickens. Proc Natl Acad Sci U S A (1970) 2.93
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood (2000) 2.92
Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia. N Engl J Med (1994) 2.75
Differentiation capacity of cultured B lymphocytes from immunodeficient patients. J Clin Invest (1973) 2.65
Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability. J Immunol (1982) 2.63
Morphological and histochemical analyses of two human T-cell subpopulations bearing receptors for IgM or IgG. J Exp Med (1978) 2.58
Agammaglobulinaemia with B lymphocytes. Specific defect of plasma-cell differentiation. Lancet (1971) 2.55
Mouse pre-B cells synthesize and secrete mu heavy chains but not light chains. Cell (1980) 2.50
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood (2001) 2.50
Development and distribution of immunoglobulin-containing cells in the chicken. An immunofluorescent analysis using purified antibodies to mu, gamma and light chains. J Immunol (1971) 2.46
A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells. Clin Immunol Immunopathol (1982) 2.41
Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J Virol (1990) 2.40
Differences in susceptibility of mature and immature mouse B lymphocytes to anti-immunoglobulin-induced immunoglobulin suppression in vitro. Possible implications for B-cell tolerance to self. J Exp Med (1975) 2.40
Postnatal expansion of the natural killer and keller cell population in humans identified by the monoclonal HNK-1 antibody. J Exp Med (1982) 2.35
Differential activation requirements for virgin and memory T cells. J Immunol (1988) 2.34
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia (2009) 2.24
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol (2000) 2.13
A mammalian equivalent of the avian bursa of Fabricius. Lancet (1966) 2.11
Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest (1980) 2.11
A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci U S A (1997) 2.11
Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med (1996) 2.10
Circulating B-cells in patients with immunodeficiency. Am J Pathol (1972) 2.07
Development and function of the immunoglobulin producing system. I. Effect of bursectomy at different stages of development on germinal centers, plasma cells, immunoglobulins and antibody production. Int Arch Allergy Appl Immunol (1969) 2.06
Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J Immunol (1984) 2.06
In vitro generation of B lymphocytes in mouse foetal liver, a mammalian 'bursa equivalent'. Nature (1974) 2.05
Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia. N Engl J Med (1978) 2.05
Identification of the TCL1 gene involved in T-cell malignancies. Proc Natl Acad Sci U S A (1994) 2.02
Restriction of surface immunoglobulin determinants to lymphocytes of the plasma cell line. J Immunol (1971) 2.01
Sequential expression of immunoglobulin on developing mouse B lymphocytes: a systematic survey that suggests a model for the generation of immunoglobulin isotype diversity. J Immunol (1978) 1.99
Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense? Ann Intern Med (1987) 1.97
Tissue localization and CD8 accessory molecule expression of T gamma delta cells in humans. J Immunol (1989) 1.96
T cells can bind antigen via cytophilic IgM antibody made by B cells. J Immunol (1973) 1.95
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia (2000) 1.94
Human B cell differentiation. II. Pokeweed mitogen-responsive B cells belong to a surface immunoglobulin D-negative subpopulation. J Exp Med (1982) 1.92
Human lymphocyte differentiation antigens HB-10 and HB-11. II. Differential production of B cell growth and differentiation factors by distinct helper T cell subpopulations. J Immunol (1985) 1.91
Trajectory of DNA in the RNA polymerase II transcription preinitiation complex. Proc Natl Acad Sci U S A (1997) 1.89
Voxel-based detection of white matter abnormalities in mild Alzheimer disease. Neurology (2006) 1.89
B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states. J Immunol (1978) 1.88
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse. Leukemia (2004) 1.87
Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci U S A (2001) 1.84
Human T lymphocyte subpopulations: studies of the mechanism by which T cells bearing Fc receptors for IgG suppress T-dependent B cell differentiation induced by pokeweed mitogen. J Immunol (1979) 1.80
Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med (1986) 1.80
Role of the thymus and other central lymphoid tissues in immunological disease. Annu Rev Med (1967) 1.76
Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J Acquir Immune Defic Syndr (1991) 1.75
The primary immunodeficiencies (1). N Engl J Med (1984) 1.74
Imbalances in T cell subpopulations associated with immunodeficiency and autoimmune syndromes. Eur J Immunol (1977) 1.74
Reconstitution of recombinant chromatin establishes a requirement for histone-tail modifications during chromatin assembly and transcription. Genes Dev (2001) 1.73
Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation. J Exp Med (1979) 1.70
Evidence for an IgD homologue on chicken lymphocytes. J Immunol (1982) 1.70
Avian T cells expressing gamma delta receptors localize in the splenic sinusoids and the intestinal epithelium. J Immunol (1988) 1.70
A large subpopulation of avian T cells express a homologue of the mammalian T gamma/delta receptor. J Exp Med (1988) 1.70
Lymphoid tissue abnormalities associated with ataxia-telangiectasia. Am J Med (1966) 1.69
Atypical presentation of Wiskott-Aldrich syndrome: diagnosis in two unrelated males based on studies of maternal T cell X chromosome inactivation. Blood (1990) 1.68
Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation. J Clin Invest (1987) 1.67
Modification of B lymphocyte differentiation by anti-immunoglobulins. Contemp Top Immunobiol (1974) 1.66
The primary immunodeficiencies. N Engl J Med (1995) 1.65
Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia (2004) 1.65
An essential role for BLNK in human B cell development. Science (1999) 1.64
Ontogeny of B cells in the chicken. I. Sequential development of clonal diversity in the bursa. J Exp Med (1976) 1.63
IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help. J Immunol (1983) 1.61
A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk Res (1985) 1.61
Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans. J Exp Med (1990) 1.60
Mu heavy chains can associate with a pseudo-light chain complex (psi L) in human pre-B cell lines. Int Immunol (1989) 1.59
Pathogenesis of IgA1 protease-producing and -nonproducing Haemophilus influenzae in human nasopharyngeal organ cultures. J Infect Dis (1986) 1.58
Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia. Ann Hematol (2004) 1.57
Structural analysis of slipped-strand DNA (S-DNA) formed in (CTG)n. (CAG)n repeats from the myotonic dystrophy locus. Nucleic Acids Res (1998) 1.55
A novel cell surface molecule on early B-lineage cells. Nature (1986) 1.55
Molecular cloning of the murine BP-1/6C3 antigen: a member of the zinc-dependent metallopeptidase family. Proc Natl Acad Sci U S A (1990) 1.54
Pathogenesis of avian lymphoid leukosis. I. Histogenesis. J Natl Cancer Inst (1968) 1.54
Ontogeny of circulating immunoglobulin in normal, bursectomized and irradiated chickens. J Immunol (1969) 1.54
Impairment of T and B cell development by treatment with a type I interferon. J Exp Med (1998) 1.54
T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool. Proc Natl Acad Sci U S A (1999) 1.54
A two-stage model for development of antibody-producing cells. Clin Exp Immunol (1972) 1.53
Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry (1999) 1.53